Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-043971
Filing Date
2021-11-10
Accepted
2021-11-10 16:53:46
Documents
2
Period of Report
2021-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 19898
2 EX-24 DOCUMENT attachment1.htm EX-24 3481
  Complete submission text file 0000899243-21-043971.txt   24741
Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VAXXINITY, INC. 1717 MAIN ST STE. 3388 DALLAS TX 75201
Business Address
Hu Mei Mei (Reporting) CIK: 0001890585 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41058 | Film No.: 211397529